Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Akebia Therapeutics, Inc. - Common Stock (NQ:AKBA)

3.620 UNCHANGED
Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 136
Open 3.620
Bid (Size) 3.620 (1)
Ask (Size) 3.720 (2)
Prev. Close 3.620
Today's Range 3.620 - 3.620
52wk Range 0.9228 - 4.076
Shares Outstanding 174,537,458
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
9 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga

Performance

YTD
+90.5%
+90.5%
1 Month
-8.8%
-8.8%
3 Month
+104.5%
+104.5%
6 Month
+93.6%
+93.6%
1 Year
+281.9%
+281.9%

More News

Read More
Earnings Scheduled For May 8, 2025
Via Benzinga
Insights Ahead: Akebia Therapeutics's Quarterly Earnings
Via Benzinga
Here are the top movers in Thursday's session.
Via Chartmill
Top movers in Thursday's session
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Which stocks are gapping on Thursday?
Via Chartmill
Crude Oil Gains Over 1%; US Weekly Jobless Claims Increase
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
JOYY, Akebia Therapeutics, Microchip Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Five Below Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Stay updated with the stocks that are on the move in today's after-hours session.
Via Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Hallador Energy, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Top movers analysis one hour before the close of the markets on 2025-03-14: top gainers and losers in today's session.
Via Chartmill
Which stocks are experiencing notable movement on Friday?
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Semtech Posts Better-Than-Expected Earnings, Joins Rubrik, DocuSign, PagerDuty And Other Big Stocks Moving Higher On Friday
Via Benzinga
AKBA Stock Earnings: Akebia Therapeutics Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For March 13, 2025
Via Benzinga
Akebia Therapeutics Surges on FDA Approval for Anemia Treatment
Via MarketBeat
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga

Frequently Asked Questions

Is Akebia Therapeutics, Inc. - Common Stock publicly traded?
Yes, Akebia Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Akebia Therapeutics, Inc. - Common Stock trade on?
Akebia Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Akebia Therapeutics, Inc. - Common Stock?
The ticker symbol for Akebia Therapeutics, Inc. - Common Stock is AKBA on the Nasdaq Stock Market
What is the current price of Akebia Therapeutics, Inc. - Common Stock?
The current price of Akebia Therapeutics, Inc. - Common Stock is 3.620
When was Akebia Therapeutics, Inc. - Common Stock last traded?
The last trade of Akebia Therapeutics, Inc. - Common Stock was at 07/03/25 01:00 PM ET
What is the market capitalization of Akebia Therapeutics, Inc. - Common Stock?
The market capitalization of Akebia Therapeutics, Inc. - Common Stock is 631.83M
How many shares of Akebia Therapeutics, Inc. - Common Stock are outstanding?
Akebia Therapeutics, Inc. - Common Stock has 632M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.